DiaMedica Therapeutics EPS DMAC

Diluted earnings per share by quarter and over the last twelve months, from 2018.

DiaMedica Therapeutics' earnings per share was −$0.66 over the twelve months to Dec 31, 2021.

In its latest quarter, Q4 FY21, it was −$0.12.

Earnings per share over time

Each fiscal year is the twelve months to its fourth quarter.

Quarter	Ended	EPS	On a year earlier	Last 12 months
Q4 FY21	Dec 31, 2021	−$0.12	n/a	−$0.66
Q3 FY21	Sep 30, 2021	−$0.18	n/a	−$0.76
Q2 FY21	Jun 30, 2021	−$0.17	n/a	−$0.77
Q1 FY21	Mar 31, 2021	−$0.19	n/a	−$0.77
Q4 FY20	Dec 31, 2020	−$0.22	n/a	−$0.77
Q3 FY20	Sep 30, 2020	−$0.19	n/a	−$0.76
Q2 FY20	Jun 30, 2020	−$0.17	n/a	−$0.77
Q1 FY20	Mar 31, 2020	−$0.19	n/a	−$0.81
Q4 FY19	Dec 31, 2019	−$0.21	n/a	−$0.89
Q3 FY19	Sep 30, 2019	−$0.20	n/a	−$0.90
Q2 FY19	Jun 30, 2019	−$0.21	n/a	−$0.88
Q1 FY19	Mar 31, 2019	−$0.27	n/a	−$0.89

Companies in Drug Manufacturers - General nearest DiaMedica Therapeutics' size, closest first, today.

Company	EPS, 12 months	Growth
DMACDiaMedica Therapeutics	n/m
ARVNArvinas	$0.16
PBYIPuma Biotechnology	$0.52	−47% a year
IRWDIronwood Pharmaceuticals	$0.77
ZVRAZevra Therapeutics	$0.93
CRMDCorMedix	$2.13	+184% a year
COLLCollegium Pharmaceutical	$1.24	+19% a year
ABUSArbutus Biopharma	$0.78
NATRNatures Sunshine Products	$1.01	+36% a year
AMPHAmphastar Pharmaceuticals	$1.70	−36% a year
OMEROmeros	$1.52
Peer median	$0.97